2019 Speakers

Emil Nashi
Montréal, QC
I graduated from medical school at the University of Alberta in 1998. I then did internal medicine training at McGill University (1998-2001) where I also subsequently trained in clinical allergy (2001-2003).
I then did a masters degree in human genetics, also at McGill (2003-2004) followed by a PhD in molecular medicine at the Feinstein Institute for medical research (2004-2009) followed by a clinical fellowship in rheumatology at McGill (2009-2010). I previously worked at the McGill University health center where I was the program director in the allergy division. While I still teach basic immunology at McGill, I currently see patients exclusively at outside clinics.
Read more
Christine Song
Toronto, ON
Dr. Song received her MD at the University of British Columbia, and completed her Internal Medicine and Clinical immunology and Allergy training at the University of Toronto. She has a Master's degree in Health Practitioner Teacher Education from the University of Toronto. She is Assistant Professor and Program Director for Adult Clinical Immunology and Allergy at the University of Toronto. She practices at St. Michael's Hospital with clinical and research interest in drug hypersensitivity.
Moshe Ben-Shoshan
Montréal, QC
Dr. Ben-Shoshan graduated from The Sackler School of Medicine, Tel-Aviv, Israel and completed his fellowship in Pediatric Allergy/Clinical Immunology at Montreal Children's Hospital in 2009.
Dr. Ben-Shoshan has been granted his M.Sc. degree in Epidemiology in McGill in 2011. In 2011 he was granted the Emerging Clinician Scientist fellowship award by AllerGen NCE and in 2013 and 2019 the FRSQ junior 1 and Junior 2 salary awards respectively. In 2017 he has received the F. Estelle R. Simons award for Research by the CSACI. More recently he has established the first world-wide cohort to assess children with suspected antibiotic allergy through graded challenges and together with Dr. Bruce Mazer established the first rigorously designed and evaluated program in Canada for milk desensitization and more recently they have established protocols for peanut, tree nut and egg desensitization. He has established the largest cross- Canada registries that collect data on the diagnosis and management of food allergy, anaphylaxis, drug allergy, anaphylaxis, mast cell disorders and primary immunodeficiencies. His research has resulted in more than 100 published manuscripts. His work on the diagnostic approach of antibiotic allergy in children has led to a fundamental shift in clinical practice for the diagnosis and management of amoxicillin allergies in children. This study was named a top 10 publications worldwide for Pediatrics in 2016 by the New England Journal of Medicine Journal Watch and in 2019 he has been funded by the Canadian Institute of Health research to continue and explore this important topic. 
Dr. Ben-Shoshan is currently a physician in the division of Allergy/ Immunology at Montreal Children’s Hospital and is involved in research initiatives on anaphylaxis, chronic urticaria and immunodeficiency. 
Theme areas: food allergy, oral immunotherapy, anaphylaxis, drug allergy, chronic urticaria, mast cell disorders, primary immunodeficiency. 
Read more
Natacha Tardio
Montréal, QC
Dr. Natacha Tardio completed her Clinical Immunology and Allergy residency at McGill University in June 2016 and then went on to pursue post-doctoral training in Eosinophilic Gastrointestinal Disorders and Translational Food Allergy.
She is currently the residency training Program Director and a clinical Assistant Professor in the division of Adult Allergy and Immunology at the McGill University Health Center. 
Read more
Reza Alizadehfar
Montréal, QC
I graduated from the University of Montreal and completed my residencies in Pediatrics and Allergy and Immunology at McGill University. I completed a fellowship in primary immunodeficiency and Bone Marrow Transplantation at the Hospital for Sick Kids in Toronto.
I am an Associate Professor of Pediatrics. I practice at the clinical Allergy and Immunology Department of the Montreal Children's Hospital and the Montreal General Hospital. I am a teacher at McGill University, and I conduct research in the field of primary immunodeficiency, asthma and food allergy. I am the training program director.
Read more
Allison Haynes
St. John's, NL
Dr. Haynes completed medical school and pediatric residency at Memorial
University of Newfoundland and a Fellowship in Clinical Immunology and Allergy at
the University of Toronto. Dr. Haynes is an Assistant Professor of Pediatrics at Memorial University of Newfoundland and practices in St. John's Newfoundland and Labrador.
Harold Kim
Kitchener-Waterloo, ON
Dr. Harold Kim has been practicing as an allergist in Kitchener, Ontario for 22 years. He has appointments at Western University and McMaster University. He is the Chief/Chair of the Division of Clinical Immunology and Allergy at Western University. 
He graduated with his MD from UWO and completed Internal Medicine and Allergy training at UWO. His clinical interests include allergic conditions including asthma, allergic rhinitis and food allergy. Although clinical research has been an interest for Dr. Kim, his "extra-practice" activities have included participating in the Canadian Asthma Guidelines and the Canadian Allergen Immunotherapy Guidelines. He is co-chief editor of Allergy, Asthma and Clinical Immunology. He is the past president of the Canadian Network of Respiratory Care. He is the president of the Canadian Society of Allergy and Clinical Immunology. Also, he has lectured across Canada as well as in the United States, Europe, Asia, the Middle East and Africa. 

Dr. Kim was awarded the Dr. David McCourtie Lecture at the Canadian Society of Allergy and Clinical Immunology Annual Meeting in Quebec City 2011. 

Dr. Kim's major goal in life is to successfully raise his 5 daughters. 
Read more
Kathryn Samaan
Montréal, QC
Dave Stukus
Columbus, OH
David R. Stukus, MD is an Associate Professor of Pediatrics in the Division of Allergy and Immunology at Nationwide Children's Hospital and The Ohio State University College of Medicine in Columbus, Ohio.
Dr. Stukus received his undergraduate and medical degrees from the University of Pittsburgh. He completed his pediatric residency and Chief residency at Nationwide Children's Hospital in Columbus, Ohio followed by his fellowship in Allergy/Immunology at The Cleveland Clinic. Dr. Stukus is an active member of the American Academy of Allergy Asthma and Immunology and American College of Allergy Asthma and Immunology. In 2018, he was asked to become the first Social Media Medical Editor of the Academy. Dr. Stukus helped launch the new podcast series for the AAAAI titled “Conversations from the World of Allergy” where he interviews thought leaders, clinicians and researchers on topics pertaining to both patient care and practicing allergists. Dr. Stukus is also an active member of the American College of Allergy Asthma and Immunology, currently serving as Chair of the Annual Meeting Program Committee. Dr. Stukus is heavily involved in medical education and was a senior editor for the most recent edition of the Allergy & Immunology Board Review book and has also served as the instructor for the Allergy & Immunology curriculum that is part of the American Academy of Pediatrics PREP Board Review course since 2016. Dr. Stukus served a member of the expert panel and co-author of the National Institute of Allergy and Infectious Disease sponsored Addendum Guidelines for the Prevention of Peanut Allergy in the United States. In 2018, he accepted an invitation to join the Joint Task Force on Practice Parameters. Dr. Stukus’ research interests lie in food allergy and asthma, with a desire to better understand and implement evidence-based guidelines into clinical care. He has over 30 peer reviewed publications, 6 book chapters, and published his first textbook “Allergies and Adolescents: Transitioning to Independence” in 2018. His second textbook “Social Media for Health Care Professionals” was published this year. Lastly, Dave is best known for his pioneering work in the use of social media for distributing evidence based information. He communicates and advocates for patients through his active Twitter account @AllergyKidsDoc, where he routinely engages with the general public and colleagues from around the world. He has used his social media presence to build a platform of over 17,000 followers, to create curriculum at his institution to educate medical students and residents on social media best practices, and to build a name not only for himself, but for the specialty of Allergy & Immunology. His work led to an appearance with the popular ZDoggMD last year when he recorded a Facebook Live podcast discussing general allergy related questions and misconceptions that has reached almost 300,000 views.
Read more
Edmond Chan
Vancouver, BC
Dr. Edmond S. Chan is a Pediatric Allergist, Clinical Associate Professor at the University of British Columbia, and Head of the Division of Allergy & Immunology at BC Children’s Hospital.
He leads a food allergy research program and is a Clinical Investigator at the BC Children’s Hospital Research Institute. He is a co-author of: NIAID peanut allergy prevention guidelines, CPS/CSACI position statement on allergy prevention in infants, AGA/Joint Task Force eosinophilic esophagitis guidelines, and upcoming CSACI oral immunotherapy guidelines. He is on the Board of directors of the Canadian Society of Allergy & Clinical Immunology (CSACI), and received the 2017 Jerry Dolovich Award for excellence in clinical work, teaching, research, and serving as a leader & role model. He is a member of the scientific advisory board for Food Allergy Canada and steering committee for Canada’s National Food Allergy Action Plan. He is on the Executive of the Allergy Section of the Canadian Paediatric Society (CPS). 
Read more
Philippe Bégin
Montréal, QC
Dr. Bégin is an allergist and associate professor from Université de Montréal. He did his specialty training as well as his masters and PhD at the Université de Montréal.
He spent 2 years in Stanford University in California to compete a complementary research training on oral immunotherapy before returning to Montreal in 2014 where he started a research program focussing on the subject. His program combines clinical trials with evaluative and participative research initiatives to adress barriers for the implementation of OIT in public health care systems.  He currently practices at the CHUM and at hospital Sainte-Justine where he is the director of the Oral Immunotherapy Clinic.
Read more
Anne Ellis
Kingston, ON
Dr. Ellis is a Professor of Medicine and Chair of the Division of Allergy & Immunology at Queen’s University. Her role is one of a Clinician Scientist with approximately 70% of her academic portfolio dedicated to research. 
Dr. Ellis obtained her MD from Queen's University, and also trained in Internal Medicine at Queen's. Following this, she underwent subspecialty training in Allergy & Clinical Immunology at McMaster University in Hamilton. She returned to join the Faculty at Queen’s in September 2008. She assumed the role of the Chair of the Division of Allergy & Immunology in May 2011, and was awarded the James H. Day Chair in Allergic Diseases and Allergy Research in May 2016. Her research interests include conducting clinical trials of novel therapies for allergic rhinitis and asthma, the pathophysiology of allergic disease, and the developmental origins of atopy and asthma. 
Read more
Martin Desrosiers
Montréal, QC
Dr. Desrosiers did both medical school and his otolaryngology residency at the University of Montreal. Post-graduate training in nasal diseases at the Johns Hopkins Allergy and Asthma Institute followed his ENT training.
He is currently a Clinical professor Université de Montréal and an Associate Clinical Professor at McGill University in Montréal, Canada. 

Dr. Desrosiers specializes in nasal and sinus disorders, with special interests in medical management of difficult to treat sinus disease and endoscopic surgery of the paranasal sinuses and skull base. Current research focuses are interactions of the microbiome and immunoregulation of the sinus mucosa, host genetics and biomarkers in sinusitis, and endoscopic skull base surgery. 

Dr. Desrosiers is an internationally recognized expert in the field of chronic sinusitis. Previous efforts from this group have been seminal in demonstrating the functional link between bacterial biofilms and chronic sinusitis, leading to the identification of bacterial biofilms as an important therapeutic target and fostering the current development of several varied anti-biofilm strategies. The current ongoing research efforts in genetics and biomarkers of CRS have offered a new appreciation of different phenotypes in sinus disease and suggested new applications for extant medications. Implications of the microbiome research have led to the development of a topical probiotic formulation for the sinuses currently undergoing clinical trials. 

The continued involvement of Dr Desrosiers with the clinical management of CRS patients ensures continued consideration of the results of the studies into clinically relevant concepts and translational research of these effects in a human population. 
Read more
Carina Venter
Denver, CO
Dr. Venter is an Associate Professor of Pediatrics, Section of Allergy/Immunology at the Children's Hospital Colorado and University of Colorado Denver School of Medicine, where she is conducting research in allergy prevention and working with children with food allergies.
She is the past chair of the International Network of Dietitians and Nutritionists in Allergy, and a member of the American Academy of Allergy and Clinical Immunology (AAAAI), American College of Allergy and Clinical Immunology (ACAAI), European Academy of Allergy and Clinical Immunology (EAACI) and the British Society of Allergy and Clinical Immunology (BSACI). She is a registered dietitian in the United Kingdom, United States and South Africa. She has had publications in international journals, book chapters and edited a book on Food Hypersensitivity. She moved from the UK in 2015 where she had been performing research into allergy prevention and prevention. 

 She is a member of the EAACI and AAAAI food allergy guidelines on Allergy Prevention and was a member of the EAACI guidelines on the Diagnosis and Management of Food Allergy guidelines. She was also a member of the NICE (UK) food allergy guidelines. She was appointed to the expert panel of the National Institutes for Allergy and Infectious Diseases Peanut Allergy Prevention Guidelines. 
Read more
Eyal Grunebaum
Toronto, ON
Dr. Eyal Grunebaum obtained his medical degree from the Hebrew University, Jerusalem, Israel and completed a clinical and research fellowship in the Division of Immunology and Allergy and Immunology at the Hospital for Sick Children, Toronto, where he now serves as a clinician.
Dr. Grunebaum is also a Senior Scientist at Sickkids Research Institute, and a Professor in Pediatrics and Immunology at the University of Toronto.  
Dr. Grunebaum’s clinical and research activities focus on the diagnosis and management of inherited immune deficiencies.
Read more
Bruce Mazer
Montréal, QC
Bruce Mazer is a professor of pediatrics and the Interim Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre (RI-MUHC).
Dr. Mazer obtained his MD and trained in pediatrics at McGill University, then completed a fellowship in allergy and immunology at the National Jewish Health Center in Denver, CO. He returned to the Montreal Children’s Hospital (MCH) in 1991 and since then has remained a member of the Division of Allergy and Immunology, and of the research institute at the MCH that later merged with the RI-MUHC. He has been director of the largest pediatric allergy and immunology academic practice in Canada at the MUHC and a research director at the Meakins Christie Laboratories, McGill’s pulmonary research institute. Most recently, he was the Head of the Divisions of Allergy, Immunology and Dermatology at the MCH-MUHC. Dr. Mazer’s research focuses on a combination of human studies and animal modeling to determine new ways of changing the immune response to allergens, and to help to naturally shape immune tolerance in individuals with food allergies and asthma. His research interests include understanding the role of B-cells, plasma cells and Intravenous Immunoglobulin in tolerance and immune regulation, understanding defects in B-cell memory and antibody disorders, and developing novel biomarkers for oral tolerance and food desensitization.
Read more
Adelle Atkinson
Toronto, ON
Dr. Atkinson completed her MD at McMaster University in 1994 and went on to complete her Paediatric Residency at the University of Toronto in 1998 taking on the role of Chief Paediatric Resident in her final year.
From 1998 – 2000 Dr. Atkinson completed two years of subspecialty training in Paediatric Allergy and Clinical Immunology at the University of Toronto. After completing this program, she was offered a consultant position in the Division of Immunology and Allergy with a cross appointment to the section of Blood and Marrow Transplantation. 

Dr. Atkinson in currently an Associate Professor of Paediatrics in the Department of Paediatrics, University of Toronto and a consultant Immunologist/Allergist in the Division of Immunology and Allergy. Her clinical work focuses on patients with primary immunodeficiencies, bone marrow transplantation, and complex allergic diseases with an emphasis on reactions to food, drugs and biologics.  

Dr. Atkinson is currently the Director of Postgraduate Medical Education for the Department of Paediatrics administering the training program for over 80 paediatric residents at the University of Toronto since 2006. She is a graduate of the Education Scholar’s Program, through the Centre for Faculty Development. She is the winner of the PARO Best Residency Program (2008), the Dr. Sarita Verma Award for Mentorship and Advocacy (2009), the Harry Bain Award for teaching excellence (2014), the Department of Paediatrics Continuing Education Award (2018), the Paediatric Chairs of Canada Clinician Educator Award (2018) and the International Conference on Residency Education – Program Director of the Year award (2019). She spends over 50% of her time in medical education related activities. 

Dr. Atkinson also holds several leadership positions including Vice-Chair – Specialty Committee for Paediatrics as well as Departmental lead for CBME. 

Dr. Atkinson is also a Clinician Educator with the Royal College of Physicians and Surgeons of Canada, with a focus on the Implementation of Competency by Design. 
Read more
Donald Vinh
Montréal, QC
Lianne Soller
Vancouver, BC
Dr. Lianne Soller is the Research Manager in the Allergy clinic at BC Children’s Hospital (BCCH). Dr. Soller manages a growing food allergy research program focusing on prevention, treatment, and management of food allergy at BCCH.
She published the first real-world safety analysis of peanut oral immunotherapy in preschoolers and is developing a pilot OIT program for school-aged children, outside of research. Dr. Soller has received competitive awards including a salary award for her Doctoral research, and an international travel award to perform research in Cork, Ireland, during her Doctorate. Dr. Soller serves as the Research Advisor for the OIT fundraising committee, a parent-driven committee dedicated to raising funds for OIT and food allergy research at BC Children’s, and is the Chair of the Allied Health Section of the Canadian Society of Allergy and Clinical Immunology.
Read more
Liane Beaudette
Linda Warner
Thomas Eiwegger
Toronto, ON
Thomas Eiwegger earned his doctoral degree at the Medical University of Vienna, Austria, where he also completed his paediatric training.
He did his post Doc in the Swiss Institute of Asthma and Allergy in the group of Cezmi Akdis from 2008-2010 and after returning to the Medical University of Vienna he trained in paediatric allergy and respiratory medicine and habilitated in 2012 in Paediatrics. Thereafter he worked as principal investigator and staff physician at the level of an associate Professor at the Department of Paediatrics and Adolescent medicine. 
In summer 2015 he moved to the Hospital for Sick Children in Toronto where he holds a staff position at the Division of Allergy and Immunology and Scientist position at the Research Institute and is faculty member (Assoc. Prof) at the Department of Paediatrics and the Department of Immunology at University of Toronto.
His research focuses on mechanisms of IgE-mediated allergy. In particular he is interested in mechanisms of tolerance development to food allergens, markers thereof and the development of new treatment approaches for food allergy.
Read more
Marcus Shaker
Lebanon, NH
Dr. Shaker is Associate Professor of Pediatrics and of Community and Family Medicine at the Geisel School of Medicine at Dartmouth.
He attended medical school and completed his Pediatrics residency at the University of Virginia, remaining in Charlottesville during his fellowship in Allergy and Immunology. While in practice he earned his Masters of Science degree in Evaluative Clinical Science and Healthcare Leadership through the Dartmouth Institute for Health Policy and Clinical Practice. 

Dr. Shaker is a member of the AAAAI/ACAAI Joint Task Force on Practice Parameters, has served as vice-chairperson of the Evaluation and Outcomes Research Committee, and continues to serve on the AAAAI Health Outcomes, Education, Delivery, and Quality Committee (HEDQ). He has been active in AAAAI Annual Meeting planning, serving in HEDQ vice-representative and representative roles. His research has involved evaluation of optimal strategies for food allergy prevention during infancy and optimizing high-value practices in the care of patients with allergies and asthma.
Read more
Michael Wechsler
Denver, CO
Michael E. Wechsler is Director of the National Jewish Health (NJH)/Cohen Family Asthma Institute and Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at NJH in Denver.
Professor Wechsler’s research focuses on clinical and translational asthma with emphasis on clinical trials in asthma, novel asthma therapies, bronchial thermoplasty, asthma pharmacogenomics, and management of eosinophilic granulomatosis with polyangiitis (i.e. Churg-Strauss Syndrome, CSS). He has led studies focusing on novel biologic agents for asthma and related diseases, including benralizumab, dupilumab, mepolizumab, reslizumab, and tezepelumab. He has published more than 180 peer-reviewed manuscripts relating to asthma, CSS and eosinophilic lung diseases. He was a member of the Steering Committee and site Principal Investigator of the NIH-sponsored Asthma Clinical Research Network (ACRN, now called AsthmaNet), a multicentre asthma clinical trials consortium, and currently serves as the PI of the Denver site of the Precision Intervention in Severe/Exacerbating Asthma (PRECISE) network. A member of the American Society of Clinical Investigation, he has participated in many different task forces related to the study of eosinophilic lung diseases that were sponsored by the NIH, the FDA, the European Respiratory Society and the International Eosinophil Society. He is currently Associate Editor of the journal Chest and has served as Associate Editor of the journal Allergy and on the editorial board of the European Journal of Clinical Investigation. 
Dr. Wechsler received AB and MMSc degrees from Harvard University in Boston and an MD degree from McGill University in Montreal. He completed medical training at Beth Israel Hospital in Boston, and as part of the Harvard Combined Pulmonary and Critical Care Fellowship Training Program.
Read more
Franziska Rueff
Munich, Germany
Mariana Castells
Boston, MA
I am the Director of the Drug Hypersensitivity and Rapid Desensitization Center for inpatients and outpatients at Brigham and Women’s Hospital and perform evaluation of about 800 patients per year with drug adverse reactions, providing diagnostic and treatment options, including high risk desensitization procedures.
I am the PI of various clinical trials – IgA deficiency on patients receiving IVIG, leukotriene measurement in patients with mastocytosis, bone loss in patients with mastocytosis, and MATA grass on immunotherapy for grass pollen allergies. 

As a teacher, I give formal and informal rounds daily while attending and four times a week while on the outpatient duty. I teach Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center residents, students from Harvard Medical School, and fellows in training from the Allergy and Clinical Immunology training programs at Brigham and Women’s Hospital, Children’s Hospital, and Massachusetts General Hospital. I participate in the PD (Patient Doctor) 2 Preceptor-Student Project and formally precept two students per year in weekly 2-hour sessions. I am a mentor for the Career Development Project at the BWH and direct one mentee for three years. In the last ten years, I have directed an Introductory Course for Allergy Fellows, held at the Brigham and Women’s Hospital. The course provides an immersion in basic and clinical allergy and immunology with 25-30 core curriculum topics. The lectures are given by faculty from Brigham and Women’s Hospital including myself, Beth Israel Deaconess Medical Center, Tufts, Massachusetts General Hospital and The Children’s Hospital. Attendance at the Course has included all the Allergy Fellows in Training for the Partners hospitals and other major hospitals in Boston. Written evaluations provided yearly by participants indicate outstanding reviews. 

As a researcher, I have my own research laboratory and work on mast cell inhibitory mechanisms. I cloned the gene for LilRB4, which belongs to a family of inhibitory receptors expressed in mast cells, macrophages and NK cells. I elucidated one ligand for LilRB4, the blood vessel integrin avb3 and demonstrated that the interaction between LilRB4 and avb3 is functional, in that avb3 inhibits the antigen-induced bone marrow-derived mast cell activation and release of mediators. I have now turned my efforts to the study of an inhibitory mast cell-dependent process that leads to temporary cell desensitization and unresponsiveness to antigen. I created a cellular model for mast cell IgE-dependent temporary desensitization and provided the first molecular target of this phenomenon, the signal transduction and activator of transcription factor 6 (STAT6). The model has now provided evidence for inhibition of calcium flux during desensitization and blocking the internalization of the FceR1 receptor. 
Read more
Jean Marshall
Halifax, NS
Dr. Jean Marshall received her Ph.D. in Immunology from the University of Manchester, U.K. She completed postdoctoral training both in Manchester and at McMaster University where she became an Assistant Professor.
In 1997 she relocated to Dalhousie University in Nova Scotia, where she is a Professor and former head of the Department of Microbiology and Immunology. Dr. Marshall’s team is internationally recognized for its studies of mast cells and Toll-like receptors. Her laboratory has investigated many aspects of host defence and defined novel roles for mast cells and their mediators in responses to infection and cancer. She has published over 120 peer reviewed papers which range from basic cell biology to clinical studies and has led multidisciplinary research teams in the chronic inflammation and food allergy research areas. She is a former president of the Canadian Society for Immunology. Dr. Marshall participates in peer review for multiple funding agencies and journals. Her work has been continuously funded by CIHR for over 25 years and her team’s work has also attracted funds from a variety of other agencies. She places a particular emphasis on the laboratory training and mentoring of young scientists many of whom have gone on to successful careers.
Read more
Wade Watson
Halifax, NS
Paul Keith
Hamilton, ON
Dr. Keith obtained his medical degree and specialized in Internal Medicine at the University of Western Ontario. He trained in Allergy and Clinical Immunology at McMaster University.
He also completed a Masters in Design, Measurement and Evaluation in the Department of Clinical Epidemiology and Biostatistics at McMaster. 
He is an Associate Professor of Medicine, in the Division of Allergy and Clinical Immunology at McMaster. He is extensively involved in medical education and has an active hospital based clinical practice in adult and pediatric allergy and clinical immunology at the McMaster Site of the Hamilton Health Sciences Corporation and at the Firestone Institute of Respiratory Health at St Joseph's Healthcare in Hamilton, Ontario. 
Research interest and activities are focused on rhinitis, asthma, allergen immunotherapy, nasal polyposis, chronic urticaria, anaphylaxis and hereditary angioedema. He is a member of the Scientific Advisory Board for ARIA. He is an investigator with Allergen. He is a past President of the Canadian Society of Allergy and Clinical Immunology. He is a member of the board of directors of the Canadian Hereditary Angioedema Network (CHAEN). 
Educational activities include participation in the continuing education of physicians, allied health professionals and the community, as well as involvement in the development of practice guidelines in rhinitis, anaphylaxis and hereditary angioedema. He has published over one hundred scientific abstracts and manuscripts in peer reviewed journals 
Read more

Contact Us

613 986 5869
info@csaci.ca

FOLLOW THE MEETING AT #CSACI19

STAY UPDATED ON ALL THE LATEST